Skip to content
Clinical Trials – home
SwedenBack to Sweden

Clinical trials in Malmo – page 73

1 356 clinical trials in Malmo, Sweden across 4 research sites. Every trial is listed in the EU Clinical Trials Register and updated daily.

SwedenOur site in SwedenKliniska-Provningar.se(opens in a new tab)
Malmo at a glance
1 356
clinical trials
  • Research sites4
Type of trial
Recruitment status
Quick filters

1 356 trials in Malmo

Open in trial search

Ocular myasthenia

Not recruiting

Study on the Effectiveness and Safety of Efgartigimod in Adults with Ocular Myasthenia Gravis

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Efgartigimod Alfa
  • Sponsor:Argenx

Migraine

Not recruiting

Study on Diclofenac Potassium and Rimegepant for Treating Migraine in Patients

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years
  • Substances:Diclofenac potassium
  • Sponsor:Region Hovedstaden

Study Comparing ABP 692 and Ocrelizumab for Patients with Relapsing-Remitting Multiple Sclerosis

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years
  • Substances:Ocrelizumab
  • Sponsor:Amgen Inc.

Study on Improving Bowel Function in Patients with Low Anterior Resection Syndrome Using Glycerol Suppositories or Transanal Irrigation

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Glycerol
  • Sponsor:Region Midtjylland

Adrenal insufficiency

Not recruiting

Study on Hydrocortisone for Stress in Patients with Polymyalgia Rheumatica or Giant Cell Arteritis and Adrenal Insufficiency

Registered drug
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Hydrocortisone
  • Sponsor:Region Hovedstaden

Study of alectinib, pemetrexed, carboplatin and cisplatin in patients with resectable stage I-III non-small cell lung cancer

Registered drugNo placebo
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:Alectinib
  • Sponsor:F. Hoffmann-La Roche AG

Obesity

Not recruiting

Study on the Long-term Weight Loss Effects of Cagrilintide and Semaglutide in Adults with Obesity

Investigational
Countries:BelgiumBelgium
  • Participants:18–64 years · 65+ years
  • Substances:Cagrilintide
  • Sponsor:Novo Nordisk A/S

Study on the Safety and Effects of DNTH103 for Adults with Multifocal Motor Neuropathy

Investigational
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:DNTH103
  • Sponsor:Dianthus Therapeutics Inc.

Study of Quizartinib with Chemotherapy for Adults with Newly Diagnosed FLT3-ITD Negative Acute Myeloid Leukemia

Registered drug
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Cytarabine
  • Sponsor:Daiichi Sankyo Inc.

Cardiac amyloidosis

Not recruiting

Study to Evaluate the Safety and Effectiveness of Vutrisiran in Patients with Transthyretin Amyloidosis and Heart Disease

Registered drugNo placebo
Countries:SwedenSweden
  • Participants:18–64 years · 65+ years
  • Substances:Vutrisiran
  • Sponsor:Alnylam Pharmaceuticals Inc.

Study on Stopping Mepolizumab or Dupilumab in Patients with Severe Chronic Rhinosinusitis with Nasal Polyps After 12 Months Symptom-Free

Registered drugNo placebo
Countries:DenmarkDenmark
  • Participants:18–64 years · 65+ years
  • Substances:Dupilumab
  • Sponsor:Region Hovedstaden

Crohn's disease

Not recruiting

Study on the Safety and Effects of ORG-129 in Patients with Fibrostenotic Crohn's Disease

Investigational
Countries:AustriaAustria
  • Participants:18–64 years · 65+ years
  • Substances:ORG-129
  • Sponsor:Agomab Spain S.L.U.

Other cities in Sweden

The busiest research cities in the country

All 66 cities in Sweden

Clinical research in Malmo

What the registry says about research in the country

01 Oncology Research

Innovative trials focusing on metastatic prostate cancer treatments and breakthrough therapies for colorectal cancer. Research includes studies of novel drug combinations and targeted therapies for breast cancer patients.

  • Advanced prostate cancer treatments
  • Colorectal cancer interventions
  • Breast cancer therapy optimization
02 Neurodegenerative Disorders

Comprehensive studies on Alzheimer's disease diagnostics and treatment, including innovative research on ALS therapies. Investigations utilize advanced imaging techniques and novel therapeutic approaches.

  • Early Alzheimer's intervention
  • ALS treatment development
  • Cognitive disorder diagnostics
03 Metabolic and Chronic Conditions

Trials examining treatments for obesity and type 2 diabetes, along with innovative approaches to managing chronic kidney disease. Research focuses on biomarker-targeted treatments and lifestyle interventions.

  • Weight management therapies
  • Diabetes treatment optimization
  • Kidney disease interventions
04 Infectious Diseases

Studies evaluating vaccines for respiratory syncytial virus, HPV, and Herpes Zoster. Research aims to prevent viral infections and improve vaccination strategies in various age groups.

  • Viral infection prevention
  • Vaccine effectiveness studies
  • Immunization programs
Clinical Trials Concierge

Prefer not to search on your own, or looking for clinical trials for a rare disease?

Tell us about your condition – we search every trial in Europe and connect you with the right site.